GZMB and colorectal carcinoma: The novel findings of this study include the independent positive prognostic effect of a high combined peritumoral GZMB+ and CD68+ cell density in a primary cohort (TNM stage I-IV) and in a validation cohort (TNM stage II) in CRC patients.